Continuing Education Information
© 2018 Harborside™
Understanding the Role of Targets and Pathways in the Treatment Melanoma
A continuing education activity for nurse practitioners, PAs, clinical nurse specialists, advanced degree nurses, oncology and hematology nurses, pharmacists, and physicians.
Release date: November 27, 2018
Expiration date: November 27, 2019
Estimated time to complete activity: 3.0 hours
Certified for CE by:
Annenberg Center for Health Sciences at Eisenhower
39000 Bob Hope Drive, Dinah Shore Bldg.
Rancho Mirage, CA 92270
Journal of the Advanced Practitioner in Oncology
94 North Woodhull Road
Huntington, NY 11743
© 2018, Annenberg Center for Health Sciences at Eisenhower. All rights reserved.
This activity is supported by educational grants from Array BioPharma, Inc. and Merck Sharp & Dohme Corp.
Christan G. Bartsch, MSHS, PA-C, MPH, University of Colorado, Anschutz Medical Campus
Brianna Hoffner, MSN, ANP-BC, AOCNP®, University of Colorado Cancer Center
Lisa A. Kottschade, APRN, MSN, CNP, Mayo Clinic
Kathleen M. Madden, RN, MSN, FNP-BC, AOCNP®, APHN, Laura and Isaac Perlmutter Clinical Cancer Center at NYU Langone Medical Center
Suzanne McGettigan, MSN, CRNP, AOCN®, Abramson Cancer Center, University of Pennsylvania Health System
LeAnn B. Norris, PharmD, FCCP, BCPS, BCOP, University of South Carolina
Mollie Reed, MSN, ACNP-BC, Tennessee Oncology
Krista M. Rubin, MS, FNP-BC, Massachusetts General Hospital Cancer Center
The activity’s target audience will consist of nurse practitioners, physician assistants, clinical nurse specialists, advanced degree nurses, oncology and hematology nurses, pharmacists, and physicians.
Harborside Medical Education
Harborside Medical Education (HSME), a division of Harborside, is committed to advancing care for people with cancer and improving patient outcomes through professional continuing education (CE) activities in oncology that address practice gaps and promote change in learners’ knowledge, competence and performance in both community and academic practice settings.
After completing this educational activity, participants should be able to:
Discuss mechanisms of action, new indications and clinical data supporting emerging targeted therapies and immunotherapies used in the treatment of advanced/metastatic melanoma, including the impact these unique agents have on patient outcomes
Apply new skill sets to guide and manage treatment expectations of patients and their families
Formulate strategies to manage and mitigate potential adverse events from targeted therapies and immunotherapies used in the treatment of advanced/metastatic melanoma
Discuss the pivotal role and necessary expertise of the advanced practitioner as a leader and key contributor of the collaborative oncology healthcare team treating melanoma.
Statement of Credit—Participants who successfully complete this activity (including the submission of the post-test and evaluation form) will receive a statement of credit.
Physicians. This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the Annenberg Center for Health Sciences at Eisenhower, the Advanced Practitioner Society for Hematology and Oncology, and the Journal of the Advanced Practitioner in Oncology. The Annenberg Center is accredited by the ACCME to provide continuing medical education for physicians.
The Annenberg Center for Health Sciences at Eisenhower designates this enduring activity for a maximum of 3.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses. The Annenberg Center for Health Sciences at Eisenhower is accredited as a provider
of continuing nursing education by the American Nurses Credentialing Center’s Commission
A maximum of 3.0 contact hours may be earned for successful completion of this activity.
Provider approved by the California Board of Registered Nursing, Provider No. 13664, for 3.0 contact hours.
Pharmacists. This is a knowledge-based activity.
The Annenberg Center for Health Sciences at Eisenhower is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This program has been assigned ACPE Universal Program #0797-9999-18-223-H01-P. This program is designated for up to 3.0 contact hours (0.30 CEUs) of continuing pharmacy education credit.
All individuals in positions to control the content of this program (e.g., planners, faculty, content reviewers) are expected to disclose all financial relationships with commercial interests that may have a direct bearing on the subject matter of this continuing education activity. Annenberg Center for Health Sciences at Eisenhower has identified and resolved all conflicts of interest in accordance with the ACHS policies and procedures. Participants have the responsibility to assess the impact (if any) of the disclosed information on the educational value of the activity.
Christan G. Bartsch, MSHS, PA-C, MPH, has nothing to disclose.
Brianna Hoffner, MSN, ANP-BC, AOCNP®, has served on the advisory board for Array BioPharma, Eli Lilly, and Merck.
Lisa A. Kottschade, APRN, MSN, CNP, has served as a consultant to Array BioPharma and Bristol-Myers Squibb, and has received research support from Bristol-Myers Squibb and Novartis.
Kathleen M. Madden, RN, MSN, FNP-BC, AOCNP®, APHN, has nothing to disclose.
Suzanne McGettigan, MSN, CRNP, AOCN®, has served on speakers bureaus for Bristol-Myers Squibb, Genentech, Merck, and Novartis.
LeAnn B. Norris, PharmD, FCCP, BCPS, BCOP, has nothing to disclose.
Mollie Reed, MSN, ACNP-BC, has served as a consultant for Array Pharmaceuticals, Bristol-Myers Squibb, and Merck, and on the speakers bureaus for Bristol-Myers Squibb, Genentech, Merck, Novartis, and Taiho Oncology.
Krista M. Rubin, MS, FNP-BC, has served as a consultant for Bristol-Myers Squibb, EMD Serono, and Merck Sharp & Dohme Corp.
ANNENBERG CENTER FOR HEALTH SCIENCES AT EISENHOWER
Charles Willis, Director, Continuing Education, consults for Pfizer Inc.; all other staff at the Annenberg Center for Health Sciences at Eisenhower have no relevant commercial relationships to disclose.
Lead Nurse Planner
Dorothy Caputo, MA, BSN, RN, EduPro Resources, LLC, has nothing to disclose.
Harborside and Harborside Medical Education staff have no potential conflicts of interest to disclose.
Monique Johnson, MD, CHCP, has nothing to disclose.
Pamela Hallquist Viale, RN, MS, CNS, ANP, has nothing to disclose.
This activity has been designed to provide continuing education that is focused on specific objectives. In selecting educational activities, clinicians should pay special attention to the relevance of those objectives and the application to their particular needs. The intent of all Annenberg Center for Health Sciences at Eisenhower educational opportunities is to provide learning that will improve patient care. Clinicians are encouraged to reflect on this activity and its applicability to their own patient population.
The opinions expressed in this activity are those of the faculty and reviewers and do not represent an endorsement by Annenberg Center for Health Sciences at Eisenhower of any specific therapeutics or approaches to diagnosis or patient management.
This educational activity may contain discussion of published as well as investigational uses of agents that are not approved by the US Food and Drug Administration. For additional information about approved uses, including approved indications, contraindications, and warnings, please refer to the prescribing information for each product.
How to Earn Credit
To access the learning assessment and evaluation form online, visit https://education.annenberg.net/PTP-melanoma
Statement of Credit: Participants who successfully complete this activity (including scoring of a minimum of 70% on the learning assessment) and complete and submit the evaluation form will be able to download a statement of credit.